SYNLAB Balance Sheet Health
Financial Health criteria checks 4/6
SYNLAB has a total shareholder equity of €2.3B and total debt of €923.3M, which brings its debt-to-equity ratio to 39.5%. Its total assets and total liabilities are €4.7B and €2.3B respectively. SYNLAB's EBIT is €142.5M making its interest coverage ratio 1.6. It has cash and short-term investments of €265.0M.
Key information
39.5%
Debt to equity ratio
€923.33m
Debt
Interest coverage ratio | 1.6x |
Cash | €265.00m |
Equity | €2.34b |
Total liabilities | €2.33b |
Total assets | €4.66b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: SYAB's short term assets (€789.1M) exceed its short term liabilities (€682.9M).
Long Term Liabilities: SYAB's short term assets (€789.1M) do not cover its long term liabilities (€1.6B).
Debt to Equity History and Analysis
Debt Level: SYAB's net debt to equity ratio (28.2%) is considered satisfactory.
Reducing Debt: SYAB's debt to equity ratio has reduced from 238.5% to 39.5% over the past 5 years.
Debt Coverage: SYAB's debt is well covered by operating cash flow (39.3%).
Interest Coverage: SYAB's interest payments on its debt are not well covered by EBIT (1.6x coverage).